Contrave vs Rybelsus
Side-by-side comparison of Contrave (naltrexone HCl + bupropion HCl ER) and Rybelsus (semaglutide (oral)) across efficacy, food restrictions, monthly cost, and Medicare Bridge coverage.
Contrave
Based on the data below, Contrave wins on lower cash price ($650/mo vs $998/mo). Your situation may differ — try the personalized matcher on the homepage or compute your real out-of-pocket with the cost calculator on each medication's detail page.
Contrave
naltrexone HCl + bupropion HCl ER · Nalpropion Pharmaceuticals (Currax Pharmaceuticals)
| Field | Contrave | Rybelsus |
|---|---|---|
| Route | tablet · daily | tablet · daily |
| Avg weight loss | 5–9% | 8–10% |
| Food restriction | Avoid high-fat meals | 30-min fast required |
| Cash from | $650/mo | $998/mo |
| Savings card | — | — |
| Medicare Bridge | Tier 3 | Tier 4 |
| A1c reduction | — | −1.4% |
| FDA approved | 2014-09 | 2019-09 |
- RouteContravetablet · dailyRybelsustablet · daily
- Avg weight lossContrave5–9%Rybelsus8–10%
- Food restrictionContraveAvoid high-fat mealsRybelsus30-min fast required
- Cash fromContrave$650/moRybelsus$998/mo
- Savings cardContrave—Rybelsus—
- Medicare BridgeContraveTier 3RybelsusTier 4
- A1c reductionContrave—Rybelsus−1.4%
- FDA approvedContrave2014-09Rybelsus2019-09
Pick Contrave if…
- Cash pay matters more than peak weight loss ($650/mo cheaper)
Pick Rybelsus if…
- You want the higher peak efficacy (10% vs 9%)
Not sure which fits?
The 30-second matcher on the homepage scores every 2026 GLP-1 against your goals + preferences and recommends the best fit.